OncoQuest

About:

OncoQuest is a Edmonton-based biopharmaceutical company.

Top Investors: Hepalink

Description:

The Company has assembled several bioactive technologies, including human and xenotypic monoclonal antibodies of the IgG and IgE class that can induce tumor specific immunity and enhance clinical outcome. Several of the lead components have clinical track records and extensive development dossiers that can be exploited to be integral to combinatorial immunooncology treatment strategies.

Total Funding Amount:

$69M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Edmonton, Alberta, Canada

Founded Date:

2015-01-01

Contact Email:

info(AT)oncoquestinc.com

Founders:

Hany Awadalla

Number of Employees:

11-50

Last Funding Date:

2020-03-13

IPO Status:

Private

Industries: